Summary: Using kilohertz frequency nerve block on vagus nerve pathways may reduce inflammation, a new study reports.
Source: Georgia Institute of Technology.
Kilohertz frequency electrical block of afferent vagus nerve pathways allows targeted stimulation to reduce inflammation in vivo.
Is a treatment only making things better or maybe also making some things a little worse?
That can be a nagging question in some medical decisions, where side effects are possible. But researchers at the Georgia Institute of Technology have figured out a way to keep what helps, while blocking what harms, in a therapy to fight serious chronic inflammatory diseases.
It’s simple and works a little like a pacemaker: An implanted device electrically stimulates the vagus nerve, but, in addition, inhibits unwanted nerve activity in a targeted manner.
Forms of vagus nerve stimulation treatment have already been successfully tested in humans by private industry with the intent to market them to patients. But the innovation by Georgia Tech researchers of adding an inhibiting signal could increase the clinical efficacy and therapeutic benefit of existing treatments.
Temporarily snipping a nerve
“We use an electrode with a kilohertz frequency that blocks unwanted nerve conduction in addition to the electrode that stimulates nerve activity,” said principal investigator Robert Butera, a professor jointly appointed in Georgia Tech’s School of Electrical and Computer Engineering and the Wallace H. Coulter Dept. of Biomedical Engineering. “We’ve arranged the two near each other, so the blocking electrode forces the stimulation from the stimulating electrode to only go in one direction.”
The researchers’ innovation could theoretically by implemented relatively quickly by augmenting existing clinical devices. So far, tests in rats have returned very encouraging results, and they have been achieved without taking more drastic measures notable in other experiments to optimize this kind of treatment – such as a vagotomy, the cutting of part of the vagus.
“The original studies in animals on the anti-inflammatory benefits of vagus nerve stimulation resorted to nerve transections to achieve directional stimulation as well as boost effectiveness of nerve stimulation. But cutting the vagus is not clinically viable – due to the multitude of vital bodily functions it monitors and regulates. Our approach provides the same therapeutic benefit, but is also immediately reversible, controllable, and clinically feasible,” said lead researcher Yogi Patel, a bioengineering graduate student.
“We call it a virtual vagotomy,” Butera said.
Patel, Butera and former Georgia Tech researchers Tarun Saxena and Ravi V. Bellamkonda, published the results of their study in the journal Scientific Reports on Thursday, January 5, 2016. The research was funded by the National Institutes of Health and the Ian’s Friends Foundation.
Vagus nerve: What is it?
To understand how this new bioelectronic fine-tuning works, let’s start with the vagus nerve itself.
It lies outside the spinal column and runs in two parts down the front of your neck on either side. It’s easy to forget about because, though it does help you feel some limited sensations like pain and heat from a handful of internal organs, those sensations are not as blatant and common as when you reach out and touch something with your hand.
Your voluntary, or somatic, nervous system is responsible for the reaching, touching, and feeling, and the vagus nerve belongs to your involuntary nervous system – actually called the autonomic nervous system. Though you may experience the effects less consciously, you couldn’t survive without a vagus.
“The vagus nerve conveys an incredible amount of information related to the state and function of the visceral organs – your digestive tract, your heart, your lungs, information about the nutrients you eat – anything required for homeostasis (physiological balance),” Patel said.
The vagus nerve is the lifeline between the vital function control centers of your brain and your visceral organs, passing messages constantly between your hypothalamus and organs to control things like pulse and respiration, the lubrication of sinuses, and the limiting of immune response.
Inflammation: What role does the vagus nerve play?
That last one is where inflammation comes in. When the immune system becomes hyperactive, it can attack not just pathogens but also healthy tissue, as with patients suffering from diseases such as rheumatoid arthritis, irritable bowel syndrome or Crohn’s disease. Drug-based therapies often fail to significantly benefit them.
The two parts of the autonomic (involuntary) nervous system — the sympathetic and the parasympathetic — strongly influence your immune system. The vagus nerve belongs to the parasympathetic.
“It’s like a seesaw system. Your sympathetic nervous system helps kick the immune system on, and the parasympathetic nervous system tempers it,” Patel said.
Electrical stimulation is good: Any downsides?
Stimulating the vagus nerve supports that tempering effect, but it can also somewhat excite the part of the nervous system that stimulates the immune response, which is counterproductive.
“Every circuit has a path coming from the brain and one going to the brain, and when you stimulate electrically, you usually have no control over which one you get. You usually get both.” Patel said. These paths are often in the same nerve being stimulated.
The path leaving the brain and going toward other organs, called the efferent pathway, is the one to stimulate to help relieve chronic inflammatory conditions. The one going to the brain, called the afferent pathway, if stimulated, leads eventually to the hypothalamus, a pea-sized region in the center of the brain, which triggers a chain of hormonal responses, eventually releasing cytokines, messaging molecules that promote inflammation.
“You get a heightened inflammatory response when you stimulate the afferent pathways, which are actively conveying information about your internal state and trigger the immune system when necessary,” Patel said. “And if a patient is already in a hyperactive immune state, you don’t want to push that even more.”
“When chronically inflamed, the body essentially thinks it’s in attack mode the entire time,” Patel said. “So, the ability to dampen the loop that results in more and more cytokines being produced is one way to shut down that cyclic process of more and more inflammation.”
Stimulating downward (efferent), while blocking upward (afferent) vagus nerve activity keeps the good effect while preventing possible bad effects. In animals that received this treatment, blood tests showed that inflammation markedly decreased. Most importantly, this treatment can be turned on or off, and be tuned to the needs of each patient.
About this neurology research article
No additional authors were involved in the study, which was performed at Georgia Tech. Two of the authors, Saxena and Bellamkonda, are now at Duke University.
Funding: Research was funded by the National Institutes of Health (grant 2R01EB016407) and Ian’s Friends Foundation. All findings, conclusions, and opinions are those of the authors and do not represent views of the funding agencies.
Source: Ben Brumfield – Georgia Institute of Technology Image Source: NeuroscienceNews.com images are credited to Georgia Tech, Robert Butera and Rob Felt. Original Research: Full open access research for “Kilohertz frequency nerve block enhances anti-inflammatory effects of vagus nerve stimulation” by Yogi A. Patel, Tarun Saxena, Ravi V. Bellamkonda and Robert J. Butera in Scientific Reports. Published online January 5 2017 doi:10.1038/srep39810
Cite This NeuroscienceNews.com Article
[cbtabs][cbtab title=”MLA”]Georgia Institute of Technology “Buzzing the Vagus Nerve Just Right to Fight Inflammatory Disease.” NeuroscienceNews. NeuroscienceNews, 60 January 2017. <https://neurosciencenews.com/dbs-vagus-nerve-5882/>.[/cbtab][cbtab title=”APA”]Georgia Institute of Technology (2017, January 60). Buzzing the Vagus Nerve Just Right to Fight Inflammatory Disease. NeuroscienceNew. Retrieved January 60, 2017 from https://neurosciencenews.com/dbs-vagus-nerve-5882/[/cbtab][cbtab title=”Chicago”]Georgia Institute of Technology “Buzzing the Vagus Nerve Just Right to Fight Inflammatory Disease.” https://neurosciencenews.com/dbs-vagus-nerve-5882/ (accessed January 60, 2017).[/cbtab][/cbtabs]
Kilohertz frequency nerve block enhances anti-inflammatory effects of vagus nerve stimulation
Efferent activation of the cervical vagus nerve (cVN) dampens systemic inflammatory processes, potentially modulating a wide-range of inflammatory pathological conditions. In contrast, afferent cVN activation amplifies systemic inflammatory processes, leading to activation of the hypothalamic-pituitary-adrenal (HPA) axis, the sympathetic nervous system through the greater splanchnic nerve (GSN), and elevation of pro-inflammatory cytokines. Ideally, to clinically implement anti-inflammatory therapy via cervical vagus nerve stimulation (cVNS) one should selectively activate the efferent pathway. Unfortunately, current implementations, in animal and clinical investigations, activate both afferent and efferent pathways. We paired cVNS with kilohertz electrical stimulation (KES) nerve block to preferentially activate efferent pathways while blocking afferent pathways. Selective efferent cVNS enhanced the anti-inflammatory effects of cVNS. Our results demonstrate that: (i) afferent, but not efferent, cVNS synchronously activates the GSN in a dose-dependent manner; (ii) efferent cVNS enabled by complete afferent KES nerve block enhances the anti-inflammatory benefits of cVNS; and (iii) incomplete afferent KES nerve block exacerbates systemic inflammation. Overall, these data demonstrate the utility of paired efferent cVNS and afferent KES nerve block for achieving selective efferent cVNS, specifically as it relates to neuromodulation of systemic inflammation.
“Kilohertz frequency nerve block enhances anti-inflammatory effects of vagus nerve stimulation” by Yogi A. Patel, Tarun Saxena, Ravi V. Bellamkonda and Robert J. Butera in Scientific Reports. Published online January 5 2017 doi:10.1038/srep39810